Literature DB >> 16284495

Trends in cervical cancer incidence--Indian scenario.

Nandagudi Srinivasa Murthy1, Kishore Chaudhry, Sunita Saxena.   

Abstract

Cancer of the uterine cervix is the second most common cancer among women in the world after breast cancer. It is the most common cancer among Indian women. The present communication reports the trends in the incidence rate of cervical cancer for the Indian population. The data published in Cancer Incidence in Five Continents for various Indian registries for different periods and/or publication by the individual registry served as the source material. During the years 1990-1997, the age-adjusted incidence rates (AAR) for cervical cancer varied from 10.9 to 65.4 amongst various registries. The highest incidence was noted in the Ambillikai registry. The age-specific incidence rates (ASIR) for cervical cancer revealed that the disease increases from 35 years and reaches a peak between the ages 55 to 64 years. The trend analysis by period showed a decreasing trend in the incidence rate of cervical cancer in all the registries. However, the decrease was very small. The mean annual percentage decrease in the AAR ranged from 0.9 to 2.6% amongst various registries. Analysis of the data by ASIR revealed that the mean annual percentage decrease was higher for women in earlier age groups in most of the registries. For women beyond 64 years, the disease incidence showed an increasing trend or minimal decrease. It was also noted that most of the cervical cancer cases were detected with regional spread of the disease and a very small proportion were diagnosed at a localized stage. In India, an organized mass-screening programme with Pap smear for early detection of cervical cancer is not in practice. The data suggest an urgent need for initiation of community screening and educational programmes for the control and prevention of cervical cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16284495     DOI: 10.1097/00008469-200512000-00004

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  7 in total

Review 1.  Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness.

Authors:  I Mattheij; A M Pollock; P Brhlikova
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group.

Authors:  Shuang Li; Ting Hu; Weiguo Lv; Hang Zhou; Xiong Li; Ru Yang; Yao Jia; Kecheng Huang; Zhilan Chen; Shaoshuai Wang; Fangxu Tang; Qinghua Zhang; Jian Shen; Jin Zhou; Ling Xi; Dongrui Deng; Hui Wang; Shixuan Wang; Xing Xie; Ding Ma
Journal:  Oncologist       Date:  2013-09-16

3.  The Incidence and Mortality of Cervical Cancer in Ningbo during 2006-2014, China.

Authors:  Hui Li; Donghui Duan; Jiaying Xu; Qinghai Gong; Yong Wang; Wei Ji; Lingbin DU; Liyuan Han; Guozhang Xu
Journal:  Iran J Public Health       Date:  2017-10       Impact factor: 1.429

4.  Burden of cervical cancer and role of screening in India.

Authors:  Saurabh Bobdey; Jignasa Sathwara; Aanchal Jain; Ganesh Balasubramaniam
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Oct-Dec

5.  Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study.

Authors:  Mayank Singh; Ravi Prakash Jha; Neha Shri; Krittika Bhattacharyya; Priyanka Patel; Deepak Dhamnetiya
Journal:  BMC Cancer       Date:  2022-02-07       Impact factor: 4.430

6.  Prevalence of cervical dysplasia in western Uttar Pradesh.

Authors:  Kamna Gupta; Nisha Puniya Malik; Veena K Sharma; Nidhi Verma; Abhilasha Gupta
Journal:  J Cytol       Date:  2013-10       Impact factor: 1.000

7.  Effectiveness of two different HDR brachytherapy regimens with the same BED value in cervical cancer.

Authors:  Kamlesh Passi; Than S Kehwar; Meenakshi Mittal; Bikramjit Singh; Rajesh Vashistha; Sureshchandra J Gupta; J V Yakhmi
Journal:  J Contemp Brachytherapy       Date:  2010-07-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.